Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tilray Brands, Inc. (TLRY:NASDAQ), powered by AI.
Tilray Brands, Inc. is currently trading at $4.88. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tilray Brands, Inc. on Alpha Lenz.
Tilray Brands, Inc.'s P/E ratio is -0.2.
“Tilray Brands, Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -88.3%.”
Ask for details →Tilray Brands Inc. is a pioneering player in the emerging global cannabis industry. A diversified company, it engages in the research, cultivation, production, and distribution of cannabis and hemp-based products. Tilray's primary function is to develop, produce, and distribute a wide range of medicinal and recreational cannabis products, including dried flower, extracts, and edibles. The company also produces hemp foods and alcoholic beverages. Founded in 2013, Tilray has rapidly gained a significant foothold, serving both medical patients and recreational consumers in multiple countries, including Canada, the United States, and parts of Europe. Tilray Brands Inc. operates within an industry that intersects with pharmaceuticals, consumer goods, and agriculture, heavily impacting sectors such as healthcare, wellness, and food and beverages. Through strategic acquisitions and partnerships, Tilray broadens its product offerings and global market presence. Its emphasis on research and innovation propels its market significance, especially as the demand for alternative wellness products grows. With the cannabis sector continuing to evolve, Tilray is poised as a key contributor to shaping market dynamics, establishing itself as a reputable brand committed to high-quality cannabis and cannabinoid-based products.
“Tilray Brands, Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -88.3%.”
Ask for details →Tilray Brands, Inc. (ticker: TLRY) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,842 employees. Market cap is $434M.
The current price is $4.88 with a P/E ratio of -0.2x and P/B of 0.29x.
ROE is -88.27% and operating margin is -13.13%. Annual revenue is $821M.